Total Payments
$4,932
2024 Payments
$4,305
Companies
11
Transactions
27
Medicare Patients
4,142
Medicare Billing
$376,099
Payment Breakdown by Category
Consulting$2,833 (57.4%)
Food & Beverage$1,209 (24.5%)
Travel$790.65 (16.0%)
Education$99.99 (2.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,833 | 2 | 57.4% |
| Food and Beverage | $1,209 | 22 | 24.5% |
| Travel and Lodging | $790.65 | 2 | 16.0% |
| Education | $99.99 | 1 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SOBI, INC | $2,583 | 3 | $0 (2024) |
| ABBVIE INC. | $1,348 | 11 | $0 (2024) |
| Amgen Inc. | $235.24 | 3 | $0 (2024) |
| Horizon Therapeutics plc | $217.37 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $146.44 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $123.97 | 1 | $0 (2022) |
| Aurinia Pharma U.S., Inc. | $113.40 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $99.99 | 1 | $0 (2023) |
| Organon Llc | $24.23 | 1 | $0 (2024) |
| Horizon Pharma plc | $22.91 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,305 | 19 | SOBI, INC ($2,583) |
| 2023 | $480.09 | 6 | Horizon Therapeutics plc ($217.37) |
| 2022 | $123.97 | 1 | AstraZeneca Pharmaceuticals LP ($123.97) |
| 2018 | $22.91 | 1 | Horizon Pharma plc ($22.91) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: Dermatology | ||||||
| 11/27/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $425.00 | General |
| 11/22/2024 | SOBI, INC | — | Consulting Fee | Cash or cash equivalent | $2,407.50 | General |
| 11/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $139.86 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $50.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.54 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.83 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $87.34 | General |
| Category: Bone Health | ||||||
| 07/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: INFLIXIMAB | ||||||
| 05/08/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $116.10 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $567.21 | General |
| Category: IMMUNOLOGY | ||||||
| 05/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $47.83 | General |
| Category: IMMUNOLOGY | ||||||
| 05/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $38.26 | General |
| Category: IMMUNOLOGY | ||||||
| 05/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: IMMUNOLOGY | ||||||
| 05/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $223.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: Inflammation | ||||||
| 10/09/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: KRYSTEXXA | ||||||
| 05/05/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Pain Management | ||||||
| 04/20/2023 | Aurinia Pharma U.S., Inc. | — | Food and Beverage | In-kind items and services | $113.40 | General |
| 04/03/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 03/22/2023 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $195.30 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 3,145 | 19,834 | $1.2M | $313,118 |
| 2022 | 33 | 997 | 2,539 | $219,911 | $62,981 |
Total Patients
4,142
Total Services
22,373
Medicare Billing
$376,099
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 19 | 10,500 | $325,500 | $79,719 | 24.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 61 | 3,900 | $237,900 | $71,412 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 247 | 616 | $186,648 | $61,269 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 95 | 95 | $56,145 | $11,658 | 20.8% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 59 | 101 | $42,418 | $9,916 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 122 | $25,376 | $8,906 | 35.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 45 | 69 | $59,271 | $8,132 | 13.7% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 68 | 106 | $40,174 | $7,167 | 17.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 267 | 460 | $18,860 | $4,730 | 25.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 28 | $10,332 | $4,357 | 42.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 267 | 488 | $5,368 | $4,071 | 75.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 92 | 92 | $27,876 | $4,005 | 14.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 257 | 438 | $13,578 | $3,310 | 24.4% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 51 | 101 | $11,220 | $3,233 | 28.8% |
| 76881 | Complete ultrasound scan of joint | Office | 2023 | 56 | 68 | $33,388 | $3,192 | 9.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 102 | 107 | $10,272 | $3,104 | 30.2% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2023 | 20 | 134 | $7,906 | $2,232 | 28.2% |
| 20604 | Aspiration and/or injection of fluid from small joint using ultrasound guidance | Office | 2023 | 23 | 33 | $9,828 | $2,228 | 22.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 26 | 26 | $3,302 | $1,971 | 59.7% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 207 | 356 | $7,476 | $1,793 | 24.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 108 | $13,824 | $1,283 | 9.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 22 | 22 | $9,790 | $1,258 | 12.8% |
| 86160 | Measurement of complement (immune system proteins), antigen, | Office | 2023 | 37 | 90 | $3,690 | $1,058 | 28.7% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 13 | 26 | $3,172 | $960.48 | 30.3% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 208 | 355 | $3,905 | $932.82 | 23.9% |
About Dr. Charles Oshinsky, MD
Dr. Charles Oshinsky, MD is a Rheumatology healthcare provider based in Chevy Chase, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2017. The National Provider Identifier (NPI) number assigned to this provider is 1639608912.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Oshinsky, MD has received a total of $4,932 in payments from pharmaceutical and medical device companies, with $4,305 received in 2024. These payments were reported across 27 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($2,833).
As a Medicare-enrolled provider, Oshinsky has provided services to 4,142 Medicare beneficiaries, totaling 22,373 services with total Medicare billing of $376,099. Data is available for 2 years (2022–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Internal Medicine
- Location Chevy Chase, MD
- Active Since 06/08/2017
- Last Updated 01/21/2026
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1639608912
Products in Payments
- RINVOQ (Biological) $918.13
- SYNAGIS (Drug) $175.26
- COSENTYX (Drug) $146.44
- KRYSTEXXA (Biological) $138.17
- SAPHNELO (Biological) $123.97
- TREMFYA (Drug) $99.99
- EVENITY (Biological) $87.34
- TAVNEOS (Drug) $31.80
- RENFLEXIS (Drug) $24.23
- KRYSTEXXA (Drug) $22.91
- Iovera (Device) $17.53
- SKYRIZI (Biological) $4.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.